Frequently asked questions
In 2022, the Adult Neurosurgery Devices market was estimated to be worth USD xx billion.
Between 2023 and 2030, the Adult Neurosurgery Devices market is anticipated to expand at a CAGR of xx%, reaching USD xx billion in 2030.
Neuro Interventional Device is the leading segment by type.
Parkinson’s is the leading segment by application.
The Hospitals segment is expected to register the greatest CAGR during the forecast period.
North America is boosting the growth of the Adult Neurosurgery Devices market.
The top players include B. Braun Melsungen, Medtronic, Boston Scientific Corporation, and Nevro Corporation. Other major players include Abbott, Ackermann Instrumente, and Machida Endoscope.
The key market growth factors are the rising prevalence of neurological illnesses and technological improvements.
The challenges limiting market growth are the high cost of neurosurgical operations and devices and the risk of complications and adverse events.
The significant market opportunities are in the areas of telemedicine, remote monitoring, and minimally invasive and image-guided operations.